Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
17,750,268
-
Share change
-
+2,180,358
-
Total reported value
-
$5,002,997,878
-
Put/Call ratio
-
101%
-
Price per share
-
$282.02
-
Number of holders
-
199
-
Value change
-
+$659,415,345
-
Number of buys
-
126
-
Number of sells
-
75
Institutional Holders of INTERCEPT PHARMACEUTICALS IN - COM (ICPT) as of Q1 2015
As of 31 Mar 2015,
INTERCEPT PHARMACEUTICALS IN - COM (ICPT) was held by
199 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,750,268 shares.
The largest 10 holders included
FMR LLC, Carmignac Gestion, ORBIMED ADVISORS LLC, VANGUARD GROUP INC, Ameriprise Financial Inc, Capital World Investors, FIRST TRUST ADVISORS LP, FRED ALGER MANAGEMENT INC, JENNISON ASSOCIATES LLC, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
199
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.